🇺🇸 FDA
Patent

US 7781413

SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

granted A61KA61K38/1709

Quick answer

US patent 7781413 (SEMA3B inhibits tumor growth and induces apoptosis in cancer cells) held by The Board of Regents of the University of Texas System expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/1709